OK HB2835

Removes the age restriction (previously 18 years or younger) for patients who can legally use cannabidiol (CBD) for treatment of severe epilepsy, spasticity due to multiple sclerosis or paraplegia, intractable nausea and vomiting, and appetite stimulation with chronic wasting diseases

Expands the definition of "qualifying patient" under Oklahoma's CBD law to include any person with Lennox-Gastaut Syndrome, Dravet Syndrome, or other refractory epilepsy not adequately treated by traditional therapies, regardless of age

CBD preparations must contain no more than 0.3% tetrahydrocannabinol (THC) concentration and be delivered in liquid form

Requires written certification from an Oklahoma-licensed physician documenting the qualifying diagnosis before patients or their caretakers can legally possess CBD

Effective date: November 1, 2016